Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform
Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million […]
Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer
Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the development of STAT3 inhibitors, […]
Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases […]
Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe
Trelleborg Healthcare & Medical announces a substantial investment to expand its European biopharmaceutical manufacturing capabilities […]
Quince Therapeutics Completes the Sale of Legacy Protease Inhibitor Portfolio to Lighthouse Pharmaceuticals
Quince Therapeutics, a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced […]
Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer
Tallac Therapeutics, a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity […]
Tigermed Completes Acquisition of Marti Farm
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global […]
IASO Bio Raises Nearly $75 Million in Series C1 Funding
IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative […]
CNS Pharmaceuticals Announces Investigator-Initiated Phase 1b/2 Trial to be Conducted at the Pomeranian Medical University in Poland
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
AbbVie and Immunome, a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more